Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donna A Volpe

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Expert Opinion on Drug Discovery|February 4, 2018
The development of biological therapies for neurological diseases: moving on from previous failuresHisham Qosa, Donna A Volpe
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 11, 2022
Do differences in cell lines and methods used for calculation of IC<sub>50</sub> values influence categorisation of drugs as P-glycoprotein substrates and inhibitors?Donna A Volpe, Abhay Joshi, Vikram Arya
Pharmaceutical Research|July 23, 2024
Evaluation of In Vitro Metabolism- and Transporter-Based Drug Interactions with Sunscreen Active IngredientsMohammed Qusa, Hisham Qosa, Donna A Volpe
The AAPS Journal|December 17, 2013
Use of different parameters and equations for calculation of IC₅₀ values in efflux assays: potential sources of variability in IC₅₀ determinationDonna A Volpe, Salaheldin S Hamed, Lei K Zhang
Cancer Chemotherapy and Pharmacology|August 15, 2018
In vitro UGT1A1 inhibition by tyrosine kinase inhibitors and association with drug-induced hyperbilirubinemiaHisham Qosa, Brittany R Avaritt, Neil R Hartman, et al.
Advanced Drug Delivery Reviews|August 2, 2017
Evaluation of transporters in drug development: Current status and contemporary issuesSue-Chih Lee, Vikram Arya, Xinning Yang, et al.
Journal of Pharmacological and Toxicological Methods|June 7, 2021
Characterization of a commercially available line of iPSC hepatocytes as models of hepatocyte function and toxicity for regulatory purposesHisham Qosa, Alexandre J S Ribeiro, Neil R Hartman, et al.
Cancer Chemotherapy and Pharmacology|March 12, 2004
In vitro and in vivo effects of acetyldinaline on murine megakaryocytopoiesisDonna A Volpe, Patricia M LoRusso, Brenda J Foster, et al.
Journal of Pharmaceutical Sciences|September 12, 2018
Methadone Metabolism and Drug-Drug Interactions: In Vitro and In Vivo Literature ReviewDonna A Volpe, Yun Xu, Chandrahas G Sahajwalla, et al.
Journal of Liposome Research|October 24, 2009
Effect of altered temperature storage on the in vitro cellular uptake of liposome drug productsDonna A Volpe, Arthur B Shaw, Xiao-Hong Chen, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Expert Opinion on Drug Discovery|February 4, 2018
The development of biological therapies for neurological diseases: moving on from previous failuresHisham Qosa, Donna A Volpe
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 11, 2022
Do differences in cell lines and methods used for calculation of IC<sub>50</sub> values influence categorisation of drugs as P-glycoprotein substrates and inhibitors?Donna A Volpe, Abhay Joshi, Vikram Arya
Pharmaceutical Research|July 23, 2024
Evaluation of In Vitro Metabolism- and Transporter-Based Drug Interactions with Sunscreen Active IngredientsMohammed Qusa, Hisham Qosa, Donna A Volpe
The AAPS Journal|December 17, 2013
Use of different parameters and equations for calculation of IC₅₀ values in efflux assays: potential sources of variability in IC₅₀ determinationDonna A Volpe, Salaheldin S Hamed, Lei K Zhang
Cancer Chemotherapy and Pharmacology|August 15, 2018
In vitro UGT1A1 inhibition by tyrosine kinase inhibitors and association with drug-induced hyperbilirubinemiaHisham Qosa, Brittany R Avaritt, Neil R Hartman, et al.
Advanced Drug Delivery Reviews|August 2, 2017
Evaluation of transporters in drug development: Current status and contemporary issuesSue-Chih Lee, Vikram Arya, Xinning Yang, et al.
Journal of Pharmacological and Toxicological Methods|June 7, 2021
Characterization of a commercially available line of iPSC hepatocytes as models of hepatocyte function and toxicity for regulatory purposesHisham Qosa, Alexandre J S Ribeiro, Neil R Hartman, et al.
Cancer Chemotherapy and Pharmacology|March 12, 2004
In vitro and in vivo effects of acetyldinaline on murine megakaryocytopoiesisDonna A Volpe, Patricia M LoRusso, Brenda J Foster, et al.
Journal of Pharmaceutical Sciences|September 12, 2018
Methadone Metabolism and Drug-Drug Interactions: In Vitro and In Vivo Literature ReviewDonna A Volpe, Yun Xu, Chandrahas G Sahajwalla, et al.
Journal of Liposome Research|October 24, 2009
Effect of altered temperature storage on the in vitro cellular uptake of liposome drug productsDonna A Volpe, Arthur B Shaw, Xiao-Hong Chen, et al.
Pageof 5